Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date Sort ascending
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
Projects for Enhancing Regional Cancer Treatment
Release Date:
Partner: Japanese Society of Clinical Oncology
Review Process: Expert Review Panel
Translation: Japanese (link)
Quality Improvement Oncology Japan
Addressing Knowledge Gaps in Aplastic Anemia
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Rare Disease Canada
Cancer Registry
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Oncology Congo, The Democratic Republic
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine USA
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines Italy
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Spain
Title
Grant Type
Focus Area
Country
Application Due Date Sort ascending
Diversity in Postmarketing Drug Safety Surveillance
Release Date:
Review Process: Pfizer Internal
Research Patient Safety USA
Ulcerative Colitis (UC) Research
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Albania, Andorra, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Israel, Italy, Korea, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
Addressing Systemic Drivers of Racial Health Inequities
Release Date:
Review Process: Pfizer Internal
Quality Improvement Health Equity USA
2023 Oncology Fellowship
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Fellowship Oncology Canada
Addressing Barriers to Care: Destigmatizing Breast Cancer through Patient Education
Release Date:
Review Process: Pfizer Internal
Education Oncology Ghana, Rwanda
Emerging Science in the Management of Acute Myeloid Leukemia
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Juvenile Idiopathic Arthritis (JIA) Patient Education
Release Date:
Review Process: Expert Review Panel
Education Inflammation & Immunology USA
PARP-inhibitor Combination Treatments in Prostate Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology China
An Accord for a Healthier World: Preceptorships for Rheumatology (African French Speaking Countries Geographic Scope)
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Education Inflammation & Immunology All
Addressing Educational Barriers to Equitable Care for Patients with Immune Inflammatory Diseases
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
An Accord for a Healthier World: Digital Health Tools to Improve Multidisciplinary Patient Care
Release Date:
Review Process: Pfizer Internal
Quality Improvement Support for the Professions Senegal
Increasing Understanding of the Evolving Hemophilia Treatment Landscape
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA